LFUS vs NVDA

LFUS presents a stable deterministic health profile with a Piotroski F-Score of 5/9 and exceptionally strong liquidity (Current Ratio 2.69). However, the stock is currently trading at its 52-week high following a massive 153% one-year rally, resulting in a stretched valuation with a PEG ratio of 2.46. While the company maintains a stellar 25-quarter earnings beat track record and healthy revenue growth, the current negative net profit margin and ROE are concerning. With a technical trend score of 10/100 and bearish insider activity, the stock appears to be in a consolidation or peak phase.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.